Literature DB >> 19176196

Acute myeloid leukemia.

Margaret R O'Donnell, Frederick R Appelbaum, Steven E Coutre, Lloyd E Damon, Harry P Erba, James Foran, Jeffrey Lancet, Lori J Maness, Guido Marcucci, Peter G Maslak, Michael Millenson, Joseph O Moore, Farhad Ravandi, Friedrich Schuening, Paul Shami, B Douglas Smith, Richard M Stone, Martin S Tallman, Eunice Wang, Frank L White.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 19176196     DOI： 10.6004/jnccn.2008.0074

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  2 in total

1.  Combining the FLT3 inhibitor PKC412 and the triterpenoid CDDO-Me synergistically induces apoptosis in acute myeloid leukemia with the internal tandem duplication mutation.

Authors:  Rehan Ahmad; Suiyang Liu; Ellen Weisberg; Erik Nelson; Ilene Galinsky; Colin Meyer; Donald Kufe; Surender Kharbanda; Richard Stone
Journal:  Mol Cancer Res       Date:  2010-06-22       Impact factor: 5.852

2.  Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukaemia (OPAL): a randomised open-label phase 2 study.

Authors:  Jorge Cortes; Eric Feldman; Karen Yee; David Rizzieri; Anjali S Advani; Anthony Charman; Richard Spruyt; Martin Toal; Hagop Kantarjian
Journal:  Lancet Oncol       Date:  2013-02-28       Impact factor: 41.316
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.